9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline

C105H88F5N27O2 — CID 163423600

IUPAC9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline
SMILESCN1CCN(Cc2ccc(NC(=O)c3nc4ccc5[nH]ncc5c4c4c3CCCC4)cc2C(F)(F)F)CC1.Cc1[nH]ncc1-c1cc(-c2ccccc2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(C2CC2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(Nc2cccc(F)c2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(Oc2cccc(F)c2)c2c(ccc3[nH]ncc32)n1
InChIInChI=1S/C28H29F3N6O.C20H15FN6.C20H14FN5O.C20H15N5.C17H15N5/c1-36-10-12-37(13-11-36)16-17-6-7-18(14-22(17)28(29,30)31)33-27(38)26-20-5-3-2-4-19(20)25-21-15-32-35-23(21)8-9-24(25)34-26;1-11-14(9-22-26-11)18-8-19(24-13-4-2-3-12(21)7-13)20-15-10-23-27-16(15)5-6-17(20)25-18;1-11-14(9-22-25-11)18-8-19(27-13-4-2-3-12(21)7-13)20-15-10-23-26-16(15)5-6-17(20)24-18;1-12-15(10-21-24-12)19-9-14(13-5-3-2-4-6-13)20-16-11-22-25-17(16)7-8-18(20)23-19;1-9-12(7-18-21-9)16-6-11(10-2-3-10)17-13-8-19-22-14(13)4-5-15(17)20-16/h6-9,14-15H,2-5,10-13,16H2,1H3,(H,32,35)(H,33,38);2-10H,1H3,(H,22,26)(H,23,27)(H,24,25);2-10H,1H3,(H,22,25)(H,23,26);2-11H,1H3,(H,21,24)(H,22,25);4-8,10H,2-3H2,1H3,(H,18,21)(H,19,22)
InChIKeyAKOUPPHQHAOPEL-UHFFFAOYSA-N
MW1855.04 g/mol
LogP22.61
Rot. Bonds14

About 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline

9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline (PubChem CID 163423600) has the molecular formula C105H88F5N27O2 and a molecular weight of 1855.04 g/mol. Its IUPAC name is 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline.

Molecular Properties

Compound Name9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline
PubChem CID163423600
Molecular FormulaC105H88F5N27O2
Molecular Weight1855.04 g/mol
Exact Mass1853.75
IUPAC Name9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline
SMILESCN1CCN(Cc2ccc(NC(=O)c3nc4ccc5[nH]ncc5c4c4c3CCCC4)cc2C(F)(F)F)CC1.Cc1[nH]ncc1-c1cc(-c2ccccc2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(C2CC2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(Nc2cccc(F)c2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(Oc2cccc(F)c2)c2c(ccc3[nH]ncc32)n1
InChIInChI=1S/C28H29F3N6O.C20H15FN6.C20H14FN5O.C20H15N5.C17H15N5/c1-36-10-12-37(13-11-36)16-17-6-7-18(14-22(17)28(29,30)31)33-27(38)26-20-5-3-2-4-19(20)25-21-15-32-35-23(21)8-9-24(25)34-26;1-11-14(9-22-26-11)18-8-19(24-13-4-2-3-12(21)7-13)20-15-10-23-27-16(15)5-6-17(20)25-18;1-11-14(9-22-25-11)18-8-19(27-13-4-2-3-12(21)7-13)20-15-10-23-26-16(15)5-6-17(20)24-18;1-12-15(10-21-24-12)19-9-14(13-5-3-2-4-6-13)20-16-11-22-25-17(16)7-8-18(20)23-19;1-9-12(7-18-21-9)16-6-11(10-2-3-10)17-13-8-19-22-14(13)4-5-15(17)20-16/h6-9,14-15H,2-5,10-13,16H2,1H3,(H,32,35)(H,33,38);2-10H,1H3,(H,22,26)(H,23,27)(H,24,25);2-10H,1H3,(H,22,25)(H,23,26);2-11H,1H3,(H,21,24)(H,22,25);4-8,10H,2-3H2,1H3,(H,18,21)(H,19,22)
InChIKeyAKOUPPHQHAOPEL-UHFFFAOYSA-N
XLogP22.61
TPSA379.41 Ų
H-Bond Donors11
H-Bond Acceptors19
Rotatable Bonds14
Heavy Atoms139
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001855.04
LogP ≤ 522.61
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1019

Analyze 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline?
The IUPAC name of 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline (CID 163423600) is 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline.
What is the SMILES notation for 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline?
The canonical SMILES for 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline is CN1CCN(Cc2ccc(NC(=O)c3nc4ccc5[nH]ncc5c4c4c3CCCC4)cc2C(F)(F)F)CC1.Cc1[nH]ncc1-c1cc(-c2ccccc2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(C2CC2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(Nc2cccc(F)c2)c2c(ccc3[nH]ncc32)n1.Cc1[nH]ncc1-c1cc(Oc2cccc(F)c2)c2c(ccc3[nH]ncc32)n1.
What is the InChIKey of 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline?
The InChIKey is AKOUPPHQHAOPEL-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H29F3N6O.C20H15FN6.C20H14FN5O.C20H15N5.C17H15N5/c1-36-10-12-37(13-11-36)16-17-6-7-18(14-22(17)28(29,30)31)33-27(38)26-20-5-3-2-4-19(20)25-21-15-32-35-23(21)8-9-24(25)34-26;1-11-14(9-22-26-11)18-8-19(24-13-4-2-3-12(21)7-13)20-15-10-23-27-16(15)5-6-17(20)25-18;1-11-14(9-22-25-11)18-8-19(27-13-4-2-3-12(21)7-13)20-15-10-23-26-16(15)5-6-17(20)24-18;1-12-15(10-21-24-12)19-9-14(13-5-3-2-4-6-13)20-16-11-22-25-17(16)7-8-18(20)23-19;1-9-12(7-18-21-9)16-6-11(10-2-3-10)17-13-8-19-22-14(13)4-5-15(17)20-16/h6-9,14-15H,2-5,10-13,16H2,1H3,(H,32,35)(H,33,38);2-10H,1H3,(H,22,26)(H,23,27)(H,24,25);2-10H,1H3,(H,22,25)(H,23,26);2-11H,1H3,(H,21,24)(H,22,25);4-8,10H,2-3H2,1H3,(H,18,21)(H,19,22).
What are the key properties of 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline?
9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline has a molecular weight of 1855.04 g/mol, XLogP of 22.61, 14 rotatable bonds, 11 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 9-cyclopropyl-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;9-(3-fluorophenoxy)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinoline;N-(3-fluorophenyl)-7-(5-methyl-1H-pyrazol-4-yl)-3H-pyrazolo[4,5-f]quinolin-9-amine;N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine-7-carboxamide;7-(5-methyl-1H-pyrazol-4-yl)-9-phenyl-3H-pyrazolo[4,5-f]quinoline is sourced from PubChem (CID 163423600), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).